Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation.
Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation.
复制标题
DOI:
10.1016/j.niox.2009.05.005
复制
发表时间:
2009-08
期刊:
影响因子:
--
通讯作者:
Gladwin M
中科院分区:
文献类型:
--
作者:
Isenberg JS;Shiva S;Gladwin M
Tissue ischemia and ischemia-reperfusion (I/R) remain sources of cell and tissue death. Inability to restore blood flow and limit reperfusion injury represents a challenge in surgical tissue repair and transplantation. A central regulator of blood flow, reperfusion signaling and angiogenesis is nitric oxide (NO). De novo NO synthesis requires oxygen and is limited in ischemic vascular territories. Nitrite (NO2-) has been discovered to convert to NO via heme-based reduction during hypoxia, providing a NO synthase independent and oxygen-independent NO source. Furthermore, blockade of the matrix protein thrombospondin-1 (TSP1) or its receptor CD47 has been shown to promote down-stream NO signaling via soluble guanylate cyclase (sGC) and cGMP-dependant kinase. We hypothesized nitrite would provide an ischemic NO source that could be potentiated by TSP1-CD47 blockade enhancing ischemic tissue survival, blood flow and angiogenesis. Both low dose nitrite and direct blockade of TSP1-CD47 interaction using antibodies or gene silencing increased acute blood flow and late tissue survival in ischemic full thickness flaps. Nitrite and TSP-1 blockade both enhanced in vitro and in vivo angiogenic responses. The nitrite effect could be abolished by inhibition of sGC and cGMP signaling. Potential therapeutic synergy was tested in a more severe ischemic flap model. We found that combined therapy with nitrite and TSP1-CD47 blockade enhanced flap perfusion, survival and angiogenesis to a greater extent than either agent alone, providing approximately 100% flap survival. These data provide a new therapeutic paradigm for hypoxic NO signaling through enhanced cGMP mediated by TSP1-CD47 blockade and nitrite delivery.
登录
查看更多内容
影响因子:
20.1
作者:
Isenberg, Jeff S.;Romeo, Martin J.;Roberts, David D.
通讯作者:
Roberts, David D.
影响因子:
9
作者:
Isenberg, Jeff S.;Pappan, Loretta K.;Roberts, David D.
通讯作者:
Roberts, David D.
影响因子:
2.2
作者:
Amadeu, Thais P.;Seabra, Amedea. B.;Monte-Alto-Costa, Andrea
通讯作者:
Monte-Alto-Costa, Andrea
影响因子:
2.1
作者:
KERRIGAN, CL;STOTLAND, MA
通讯作者:
STOTLAND, MA
影响因子:
6
作者:
KNIGHT, KR;ANGEL, MF;OBRIEN, BM
通讯作者:
OBRIEN, BM